(Mary Linda Andrews, far right, with last year’s Impact Awards winners. Photo provided. Credit: Furia Rubel Communications)
By Brad Segall
NORRISTOWN, Pa. (CBS) – Time is running out for Philadelphia area healthcare nonprofit organizations to apply for $40,000 “Impact Awards” from drugmaker GlaxoSmithKline.
Up to ten nonprofits providing access to healthcare can receive $40,000 each in grant money, but the applications need to be submitted by March 28th. The organizations must be located in the five-county Philadelphia region (Philadelphia, Montgomery, Bucks, Chester, Delaware counties) or in Berks, Northampton, Lehigh, or Lancaster counties, or the City of Camden.
GlaxoSmithKline’s Mary Linda Andrews says these healthcare providers are critical, especially in tough economic times.
“More and more individuals are falling through the cracks as having either no insurance or being underinsured, and they often look to these nonprofits to provide health care,” she tells KYW Newsradio.
GSK is looking for innovative healthcare organizations making a significant impact on their communities.
“We know that these individuals need to have the health services, especially if they are living in poverty. Some are homeless and they just don’t know where to go for care,” Andrews says.
The guidelines for the competition are on their web site at GSKImpact-US.com.
MOST VIEWED GALLERIES
- PHOTOS: Angelina Jolie Through The Years
- PHOTOS: Celebrity Infidelity Scandals
- PHOTOS: Celebrity Birthdays: May
- PHOTOS: Top 20 Most Hated Hollywood Celebrities
- PHOTOS: Celebrity Photobombs



Most Romantic US Honeymoon...
GHI @Home - Metal Shingle /...
11th Annual Gary Papa 5K Run-...
Athletes We Wish Stayed In...
Tiger Woods At The US Open At...
Final Round: The U.S. Open At...
Baseball Shots Of The Week –...
Behind the Scenes: TP...
Orr At The Shore 2013
NCC Retro-Rama Party
The Philadelphia Diamonds Of...
2013 US Open At Merion
Storm Photos: June 13, 2013
WIP Morning Show Father's Day...
US Open At Merion Practice...
Julius Erving Through The...







